DJIA 15,973.84 313.66 2.00%
NASDAQ 4,337.51 70.68 1.66%
S&P 500 1,864.78 35.70 1.95%
market minute promo

Amgen (NASDAQ: AMGN)

144.72 3.26 (2.30%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

AMGN $144.72 2.30%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $143.13
Previous Close $141.46
Daily Range $141.14 - $144.97
52-Week Range $130.09 - $181.81
Market Cap $109.2B
P/E Ratio 13.63
Dividend (Yield) $4.00 (2.8%)
Ex-Dividend Date
Dividend Pay Date
02/11/16
03/08/16
Volume 3,217,517
Average Daily Volume 4,446,535
Current FY EPS $10.05

Sector

Healthcare

Industry

Drug Makers

Amgen (AMGN) Description

A biotechnology company which discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology. Website: http://www.amgen.com/

News & Commentary

Gilead Sciences Wants to Make Being a Shareholder Worth It

Huge buybacks and a commitment to dividend increases make this one of the market's friendliest biotech companies.

Novartis Filing for Neulasta Biosimilar Accepted in the EU

Amgen Valuation Now Excludes Potential Repatha Revenue

Big Biotech: Bargains Abound For Brave Investors

Gilead, Johnson & Johnson or Roche?

This FDA Panel Decision Just Changed the Game

The emergence of biosimilars leads to a shocking FDA panel decision that I guarantee you've never seen before.

Amgen, Celgene Buck Short Interest Trend In Biotech Stocks

19 Stocks You Should Own if the U.S. Falls Into a Recession

Pfizer's Biosimilar of Remicade Recommended for Approval

Regeneron Disappoints, The Stock Sells Off: Analysis Of Its Growth Potential

See More AMGN News...

AMGN's Top Competitors

AMGN $144.72 (2.30%)
Current stock: AMGN
GILD $89.44 (2.38%)
Current stock: GILD
CELG $102.45 (2.87%)
Current stock: CELG
$0.00 (0.00%)
Current stock: